Abstract:Objective To evaluate the efficacy of patients with stage T2 bladder cancer who underwent combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy.Methods The survival data of bladder cancer paients from January 2000 to December 2014 with stage T2N0M0 were retrospectively analyzed.Thirty-five patients of cT2N0M0 receive combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy(group A),and 80 patients of pT2N0M0 underwent radical cystectomy (RC) (group B).The pathological diagnosis of all patients was urothelial carcinoma.In group A,there were 33(94.2％) males and 2 (5.8％) females;20 (57.1％) tumor size less than 3 cm and 15 (42.9％) larger than 3 cm;24 (68.6％) with single tumor and 11 (31.4％) with multiple tumors;11 (31.4％) patients with primary tumors and 24 (68.6％) recurrent tumors.In group B,there were 71 (88.7％) males and 9 (11.3％) females;35 (43.8％) tumor size less than 3 cm and 45(56.2％) larger than 3 cm;44 (55.0％) with single tumors and 36 (45.0％) with multiple tumors;22(27.5％) patients with primary tumors and 58 (72.5％) recurrent tumors.Results Groups A and B consisted of 35 and 80 patients and median follow-up time was 68 (13-157)and 67 (4-198)months,respectively.There was no significantly statistical difference in disease-specific survival (DSS) between the two groups(P =0.888),76.5％ for group A and 60.6％ for group B respectively.In group A,26 (74.3％) patients achieved complete response (CR) to intra-arterial chemotherapy.Additionally,amounts of 21 (60.0％) patients preserve their functional bladder successfully and their median follow-up time was 69 (13-134)months.8 patients receive delayed radical cystectomy when suffered tumor recurrence and none of them had lymph node metastases.Of those pathological stage was presented as stage T2 5 cases,T3 2 cases and T4 1 case.Importantly,the 8 patients who receive delayed RC did not confer worse DSS when compared with those underwent immediate RC in group B (P =0.809).Cox proportional hazards model showed that tumor number and CR to intra-arterial chemotherapy was independent prognostic factor for disease-free survival (HR =0.238,P =0.007) and DSS(HR =0.085,P =0.004) respectively.During the period of intra-arterial chemotherapy,we did not observe hematological toxicity of grade Ⅳ and the hematological toxicity of grade Ⅰ-Ⅲ was 9 (25.7％),6 (17.1％) and 4 (11.4％).Conclusions For patients with T2N0M0,combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy could be a therapy with long-term survival outcome and safety.The therapy could be offered as alternative treatment option for patients who were unsuitable for receiving RC.

Internal iliac artery chemoembolization combined with transurethral electrocoagulation resection for advanced bladder cancer: preliminary results in 17 cases

Combined Modality Therapy Following Bladder Conservation Surgery for Bladder Cancers

Combinations of Internal lliac Arterial Chemotherapy and Bladderpreserving Resection for Local Invasive Bladder Cancer

Chemoembolization of internal iliac artery for the hemorrhage of advanced bladder carcinoma

The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer

Clinical effect of iliac artery interventional chemotherapy combination with bladder perfusion for high level of bladder urothelial carcinoma

Combinations of neoadjuvant chemotherapy and transurethral resection for invasive bladder cancer

Initial Results of Intra-arterial Chemotherapy for Poorly Differentiated Bladder Transitional Cell Carcinoma

Bladder Preservation by Internal Iliac Arterial Infusion Chemotherapy and Radiotherapy in Invasive Bladder Carcinoma

Efficacy of Radical Cystectomy Plus Adjuvant Intraarterial Chemotherapy with Gemcitabine and Cisplatin on Locally Advanced Bladder Cancer.

Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.

Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection

Preoperative Selective Internal Iliac Arterial Chemotherapy for Invasive Bladder Cancer

Combination Therapy of Three-Dimensional (3D) Visualisation Operative Treatment Planning System and US-guided Percutaneous Microwave Ablation in Larger Renal Cell Carcinomas (D ≥ 4 Cm): Preliminary Results

Single-dose intra-arterial infusion chemotherapy for refractory bladder cancer after transurethral resection of bladder tumor: Report of 12 cases

The Comparative Study of Intraarterial Infusion Chemotherapy and Chemoembolization in the Patients with Middle and Advanced Stage of Bladder Cancer

Multivariant therapy for invasive,multiple and recrudescent bladder carcinoma(report of 21 cases)

Clinical study on intraarterial infusion chemotherapy in treatment of invasive bladder cancer

Preliminary results of intra-artery chemotherapy for T1G3 bladder cancer

Transurethral electrovaporization combined with intravesical chemotherapy and traditional chinese medicine therapy for treatment of superficial bladder tumor

Long-term Outcomes of Combined Treatment of Bladder-Preserving Surgery and Adjuvant Intraarterial Chemotherapy for Patients with Stage T2 Bladder Cancer